Streamlined Approach to Detect Harmful Medications in Older Cancer Patients
A new study validates a targeted tool for identifying harmful medications in older adults with cancer, aiming to improve safety and treatment outcomes through careful medication review.
Recent research confirms the effectiveness of a specialized tool designed to identify potentially harmful medications in older adults undergoing cancer treatment. The study, published in the Journal of the National Comprehensive Cancer Network, evaluated the 'Geriatric Oncology Potentially Inappropriate Medications' scale (GO-PIMS), which is based on the NCCN Clinical Practice Guidelines in Oncology for Older Adult Oncology. Researchers from the Veterans Affairs Healthcare System in Boston analyzed data from over 380,000 older cancer patients, including those with solid tumors and hematologic malignancies, diagnosed between 2000 and 2022.
The findings revealed that 38% of these patients were prescribed at least one medications flagged by GO-PIMS, with selective serotonin reuptake inhibitors (SSRIs) being the most common. Notably, each additional flagged medication increased the likelihood of frailty at diagnosis by 66%, highlighting the potential impact on patient outcomes. The study underscores the importance of carefully reviewing medication lists to mitigate risks related to frailty, hospitalizations, and mortality.
Dr. Jennifer La, the lead author, emphasized that this tool can enhance patient safety by enabling healthcare providers to identify high-risk medications early in the treatment process. She advocates for integrating GO-PIMS into electronic health records to facilitate routine screening and deprescribing when appropriate. Senior author Dr. Clark DuMontier highlighted that balancing medication benefits and risks tailored to each patient is crucial. The research supports proactive medication management, especially at the point of cancer diagnosis, to improve overall treatment safety.
Furthermore, experts like Dr. Mostafa Mohamed suggest that adopting these tools into everyday clinical practice can significantly reduce medication-related risks. The ultimate goal is to optimize treatment plans by reviewing medication safety and making more informed, individualized decisions for older adults with cancer.
This innovative approach aims to make cancer care safer and more tolerable for the aging population, reducing adverse events associated with unsuitable medications.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Fruit Fly Research Links Alzheimer’s Proteins to Systemic Organ Changes and Sensory Decline
New research using fruit fly models uncovers how Alzheimer’s-related proteins Aβ42 and Tau cause widespread organ changes and sensory decline, offering new insights into systemic effects of the disease.
New Research Reveals Basal Stem-like Cells as the Origin of Small Cell Lung Cancer
A new study identifies basal stem-like cells as the origin of small cell lung cancer, highlighting new avenues for prevention and targeted treatment strategies.
Breakthrough 'Molecular Light Switch' Promises Restored Sight, Hearing, and Heart Function
A newly developed light-sensitive protein, ChReef, advances optogenetic therapy, offering promising treatment options for sight, hearing, and heart rhythm restoration with low light doses, paving the way for innovative medical applications.
New Brain Imaging Technique Uncovers Hidden Vascular Changes with Age
A groundbreaking MRI technique reveals age-related increases in tiny brain vessel pulsations, offering new insights into vascular health and neurodegenerative disease risks.